Bionomics Limited
NASDAQ:BNOX
0.2531 (USD) • At close December 23, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2002 | 2001 | 2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0.02 | 0.26 | 0 | 0.05 | 3.82 | 8.794 | 20.789 | 14.326 | 5.085 | 18.022 | 1.494 | 1.152 | 3.402 | 2.544 | 2.914 | 1.077 | 0.693 | 0.484 | 0.225 | 0.693 | 0.907 | 0.599 |
| Cost of Revenue
| 0.434 | 13.063 | 11.046 | 4.321 | 4.022 | 8.516 | 18.686 | 18.618 | 18.453 | 0 | 0 | 0 | 0 | 0 | 0 | 0.338 | 0.213 | 0.145 | 0.071 | 0.041 | 0 | 0 | 0 |
| Gross Profit
| -0.434 | -12.631 | -6.865 | -3.625 | -1.957 | -3.345 | -9.892 | 2.171 | -4.127 | 5.085 | 18.022 | 1.494 | 1.152 | 3.402 | 2.544 | 2.576 | 0.864 | 0.548 | 0.413 | 0.185 | 0.693 | 0.907 | 0.599 |
| Gross Profit Ratio
| 0 | -631.533 | -1.642 | -5.209 | -0.948 | -0.647 | -1.125 | 0.104 | -0.288 | 1 | 1 | 1 | 1 | 1 | 1 | 0.884 | 0.802 | 0.791 | 0.854 | 0.82 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 9,417.785 | 19.61 | 16 | 5.76 | 5.83 | 8.98 | 18.686 | 18.618 | 18.453 | 17.78 | 16.744 | 14.757 | 9.316 | 9.722 | 7.297 | 6.54 | 7.295 | 5.47 | 5.052 | 3.399 | 2.515 | 1.85 | 1.041 |
| General & Administrative Expenses
| 8,474.591 | 5.752 | 5.108 | 3.279 | 2.533 | 4.683 | 6.861 | 4.401 | 5.607 | 6.637 | 4.325 | 4.507 | 3.818 | 3.339 | 2.367 | 2.247 | 3.639 | 3.168 | 1.856 | 1.195 | 0.435 | 0.524 | 0 |
| Selling & Marketing Expenses
| 0 | 0.147 | 0.181 | 0.954 | 0.815 | 0.851 | 1.049 | 1.994 | 2.26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.159 | 0 | 0 | 0 |
| SG&A
| 8,474.591 | 8.86 | 7.66 | 5.65 | 4.85 | 9.35 | 7.909 | 6.395 | 7.867 | 6.637 | 4.325 | 4.507 | 3.818 | 3.339 | 2.367 | 2.247 | 3.639 | 3.168 | 1.856 | 1.195 | 0.435 | 0.524 | 0.144 |
| Other Expenses
| 0 | 0 | 0.007 | 0.203 | 0.2 | 0 | 0 | 0 | 0 | 0.879 | 0.515 | 0.497 | 0.231 | 0.823 | 0.289 | 0.141 | -2.728 | 0.658 | -0.723 | -0.039 | 0.405 | 0.244 | -0.014 |
| Operating Expenses
| 17,892.376 | 32 | 21.61 | 11.92 | 9.06 | 19.18 | 8.437 | 6.368 | 8.281 | 25.296 | 21.585 | 19.761 | 13.366 | 13.884 | 9.954 | 8.928 | 8.206 | 9.296 | 6.185 | 4.556 | 3.354 | 2.619 | 1.17 |
| Operating Income
| -17,892.376 | -31.97 | -21.34 | -11.92 | -9.01 | -15.36 | -17.801 | -4.224 | -11.994 | -20.212 | -3.563 | -18.267 | -12.213 | -10.482 | -7.41 | -6.014 | -7.128 | -8.603 | -5.701 | -4.33 | -2.662 | -1.711 | -1.17 |
| Operating Income Ratio
| 0 | -42.826 | -2.906 | -11.073 | -2.502 | -1.717 | -2.024 | -0.203 | -0.837 | -3.975 | -0.198 | -12.226 | -10.598 | -3.081 | -2.913 | -2.064 | -6.617 | -12.411 | -11.776 | -19.216 | -3.842 | -1.886 | -1.953 |
| Total Other Income Expenses Net
| 17,882.105 | -2.991 | -3.006 | 1.044 | 4.851 | 7.935 | -1.625 | -0.562 | -0.912 | 6.96 | 7.279 | 9.174 | 8.807 | -0.32 | 0.429 | 0.446 | 2.208 | 1.904 | 1.58 | 0.798 | -0.398 | -0.253 | -0.503 |
| Income Before Tax
| -10.271 | -32.05 | -21.95 | -8.88 | -6.03 | -9.91 | -19.426 | -4.786 | -12.906 | -13.252 | 3.716 | -9.092 | -3.407 | -10.802 | -6.981 | -5.568 | -4.92 | -6.7 | -4.121 | -3.532 | -3.06 | -1.965 | -1.673 |
| Income Before Tax Ratio
| 0 | -49.343 | -3.625 | -9.573 | -2.014 | -1.436 | -2.209 | -0.23 | -0.901 | -2.606 | 0.206 | -6.085 | -2.956 | -3.175 | -2.744 | -1.911 | -4.567 | -9.664 | -8.513 | -15.673 | -4.416 | -2.165 | -2.794 |
| Income Tax Expense
| -87.32 | -0.21 | -0.19 | -0.19 | -0.21 | -0.24 | 0.859 | 0.402 | 0.545 | -0.251 | 0.697 | 0.035 | -0.197 | -0.802 | 0 | -0.03 | -0.344 | -2.077 | -0.116 | 0 | 0 | 0 | -3.279 |
| Net Income
| -15,492.166 | -31.85 | -21.76 | -8.7 | -7.12 | -9.67 | -18.567 | -5.188 | -12.361 | -13 | 3.019 | -9.127 | -3.21 | -10 | -6.981 | -5.538 | -4.577 | -4.622 | -4.005 | -3.532 | -3.06 | -1.965 | -1.673 |
| Net Income Ratio
| 0 | -49.025 | -3.593 | -9.371 | -1.945 | -1.413 | -2.111 | -0.25 | -0.863 | -2.557 | 0.168 | -6.109 | -2.785 | -2.939 | -2.744 | -1.901 | -4.249 | -6.668 | -8.273 | -15.673 | -4.416 | -2.165 | -2.794 |
| EPS
| -1.02 | -0.022 | -0.016 | -0.011 | -0.013 | -0.019 | -0.069 | -0.019 | -0.049 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS Diluted
| -1.02 | -0.022 | -0.016 | -0.011 | -0.013 | -0.019 | -0.069 | -0.019 | -0.048 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA
| -9.837 | -20.897 | -11.512 | -4.974 | -4.187 | -7.873 | -16.567 | -2.885 | -10.551 | -12.589 | 4.29 | -9.021 | -3.341 | -10.475 | -6.77 | -5.34 | -4.621 | -6.441 | -3.877 | -2.893 | -2.397 | -1.68 | -1.041 |
| EBITDA Ratio
| 0 | -41.308 | -2.754 | -10.062 | -2.027 | -1.523 | -1.884 | -0.139 | -0.736 | -2.476 | 0.238 | -6.038 | -2.899 | -3.079 | -2.661 | -1.832 | -4.289 | -9.291 | -8.008 | -12.838 | -3.459 | -1.851 | -1.737 |